More than 60% of patients with relapsed or refractory KMT2Ar acute leukemia responded to the menin inhibitor revumenib.
Cancer is complicated, especially with multiple diagnoses, oncologists, tests and integrative treatments, but AI can be a ...
CURE partnered with SHARE Cancer Support to learn more about the importance of emotional well-being and a strong support ...
Lazcluze demonstrated significant CNS activity, regardless of T790M status, in treating intracranial and leptomeningeal ...
This trial is assessing CBX-12 as a potential treatment for ovarian cancer, with additional studies to be conducted in other ...
For patients with adenocarcinoma of the esophagus and esophagogastric junction, chemoradiotherapy and chemotherapy improved ...
For patients with metastatic colorectal cancer, adding a higher dose proves just as effective as the standard dose of vitamin D3, despite one exception. In patients with metastatic (spreading) ...
I’ve recently started on chemotherapy pills instead of infusions and the bitterness reminds me to accept not only the ...
First-line Keytruda plus chemotherapy is the new standard of care for patients with advanced pleural mesothelioma after the ...
In some patients with head and neck cancer, those who require dental care after cancer treatment may face financial burdens ...
The biologics license application seeks potential approval of a Darzalex Faspro-based regimen for newly diagnosed multiple ...
Several colleagues, patients and caregivers nominated Jill May, B.S.N., RN, OCN, for the 2024 Extraordinary Healer Award for ...